Bilateral dexamethasone intravitreal implant (Ozurdex®) in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis

Donato Rigante, Maria Eugenia Latronico, Francesco Caso, Luca Cantarini, Luisa Costa, Laura Nieves-Martín, Claudio Traversi, Rossella Franceschini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

12 Citazioni (Scopus)

Abstract

Vogt-Koyanagi-Harada disease (VKHD) is a multisystemic disorder characterized by granulomatous panuveitis with exudative retinal detachments, often associated with neurologic and cutaneous manifestations. Therapy relies mainly on the use of corticosteroids, administrated as oral or intravenous high-dose pulses, and immunosuppressants. However, since macular edema and retinal detachment can often be refractory to systemic therapies, intravitreal triamcinolone acetate has been used successfully. Herein, we report the first case of refractory bilateral panuveitis in a young patient with VKHD successfully treated with dexamethasone intravitreal implant.
Lingua originaleEnglish
pagine (da-a)1145-1148
Numero di pagine4
RivistaCLINICAL RHEUMATOLOGY
Volume2015
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Vogt-Koyanagi-Harada disease

Fingerprint Entra nei temi di ricerca di 'Bilateral dexamethasone intravitreal implant (Ozurdex®) in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis'. Insieme formano una fingerprint unica.

Cita questo